Back
Black Diamond Therapeutics Stock Price Chart
Sponsored
BDTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
BDTX
Black Diamond Therapeutics
Last Price:
2.57
Seasonality Move:
28.2%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight selling pressure.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.51 | Sell |
20-day SMA: | 2.86 | Sell |
50-day SMA: | 3.41 | Sell |
200-day SMA: | 4.84 | Sell |
8-day EMA: | 2.58 | Sell |
20-day EMA: | 2.82 | Sell |
50-day EMA: | 3.44 | Sell |
200-day EMA: | 4.25 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 32.64 | Sell |
Chaikin Money Flow: | -109475 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.58 - 3.18) | Sell |
Bollinger Bands (100): | (3.26 - 5.86) | Sell |
Black Diamond Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 2.47 while BDTX 8-day simple moving average is 2.51, which is a Sell signal.
- The stock price of BDTX is 2.47 while Black Diamond Therapeutics 20-day SMA is 2.86, which makes it a Sell.
- Black Diamond Therapeutics 50-day simple moving average is 3.41 while BDTX share price is 2.47, making it a Sell technically.
- BDTX stock price is 2.47 and Black Diamond Therapeutics 200-day simple moving average is 4.84, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
27
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $2.47. The Score for BDTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
139.77M
Price in USD:
2.47
Share Volume:
401.41K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
2.16
Sell
27
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 2.47 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 2.47 while BDTX 8-day exponential moving average is 2.58, which is a Sell signal.
- The stock price of BDTX is 2.47 while Black Diamond Therapeutics 20-day EMA is 2.82, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 3.44 while BDTX share price is 2.47, making it a Sell technically.
- BDTX stock price is 2.47 and Black Diamond Therapeutics 200-day simple moving average is 4.25, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 32.64, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (2.58 - 3.18), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.26 - 5.86), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.